Following the controversial births of the first gene-edited babies, a major focus of the Third International Summit on Human Genome Editing was responsible use of CRISPR.
Academic rigor, journalistic flair
Articles on Global health
Displaying 1 - 20 of 115 articles
Dangerous fungal infections are on the rise globally. But we have few drugs that work and no prospect of anti-fungal vaccines any time soon.
The US PEPFAR initiative has brought HIV medication to millions of people globally. Behind this progress are the activists that pressured politicians and companies to put patients over patents.
Through the choice of images in publications, women and children of colour in low and middle income countries were treated with less dignity and respect than those in high income countries.
The Medicines Patent Pool was created to promote public health, facilitating generic licensing for patented drugs that treat diseases predominantly affecting low- and middle-income countries.
Time is running out to expand an agreement to relax patent rules on COVID vaccines. Members of the World Trade Organization should broaden its scope to treatments and tests.
While gender-affirming health care is essential to the well-being of trans people, access to quality services varies significantly by geographic region and social context.
We found most governments were ill-prepared, too slow to act, paid too little attention to the most vulnerable, and were hampered by low public trust and an epidemic of misinformation.
It’s not just mosquitos. Flooding, extreme heat and other climate-related hazards are bringing people into contact with pathogens more often, and affecting people’s ability to fight off disease.
By late July 2022, monkeypox was present in more than 70 countries with significant spread in certain communities. As a result, the World Health Organization began taking steps to fight the virus.
An expert explains how reproductive rights are changing globally.
Twenty-six fast-growing African cities may battle health challenges if air pollution is not addressed.
Some countries report higher rates of COVID-19 cases and deaths among men. This might be due to underreporting among women with limited health access.
Latest numbers show antimicrobial resistant infections contributed to 4.95 millions deaths globally in 2019.
CORBEVAX is anticipated to significantly expand vaccine access to people in low- and middle-income countries.
If COVID symptoms are less severe, people with the Omicron variant may be less likely to test and isolate.
Researchers asked aid workers how to best prepare for the climate emergency in places where its effects are most severe.
At the beginning of 2020, most people hadn’t used the word ‘pandemic’ before. Now it’s time to understand the term ‘endemic’ and find out what to expect when COVID changes shape.
Local research is particularly needed to assess existing policies and inform efforts to implement them better.
The high costs of the world’s colossally unequal COVID-19 immunization rates.
Top contributors
-
Associate Principal Research Fellow, Burnet Institute
-
Professor of Public Health, The University of Melbourne
-
Visiting Fellow at Nossal Institute for Global Health, The University of Melbourne
-
Associate Professor, Melbourne School of Population and Global Health, The University of Melbourne
-
Director of Global Health & Professor, McGill University
-
Deputy Program Director, Health Security and Pandemic Preparedness, Burnet Institute
-
Professor of Philosophy, Binghamton University, State University of New York
-
Adjunct Associate Professor of Epidemiology, Columbia University
-
Professor in Human Geography, University of Sydney
-
Senior Professor, Kedge Business School
-
Professor of Population Nutrition and Global Health, University of Auckland
-
UNSW Sydney
-
Associate Professor in Public Health, La Trobe University
-
Professor Emeritus, Walter and Eliza Hall Institute
-
Deputy Director, Burnet Institute, Adjunct Professor, Monash University, Burnet Institute
